Proteogenomics Core for pediatric translational research
Official title: Proteogenomics Core
Funded at Arkansas Children's Hospital Res Inst · NIH-11386598 · Data updated 2026-11-12
A new Proteogenomics Core will give pediatric researchers access to expert bioinformatics, proteomics, genomics, and epigenomics analyses to speed up translational studies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arkansas Children's Hospital Res Inst NIH-funded |
| Lab location | 1 site (Little Rock, United States) |
| Project start | July 11, 2017 |
| Project end | June 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $411,236 |
| NIH project number | 5P20GM121293-10 |
| Project ID | NIH-11386598 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are pediatric patients whose diseases could be studied through proteogenomics analyses and who are involved in CTPR projects or related collaborations.
✕Less likely to help
Patients not involved in centers or projects using proteogenomics resources may not directly benefit.
What this research studies
This grant funds a dedicated Proteogenomics Core within the Center for Translational Pediatric Research to provide non-duplicative, high-level omics services. It offers access to experienced staff and state-of-the-art equipment for proteomics, genomics, and epigenomics, plus advanced data integration. The core aims to support current center projects and become sustainable through a recharge model and future collaborations. Pediatric researchers at Arkansas Children’s Hospital and affiliated sites can leverage these resources to advance understanding of pediatric diseases. The emphasis is on translating laboratory data into clinical insights that could benefit children with disorders treated at the center.
Why it matters
Potential benefit: If successful, it could accelerate discovery and translation of pediatric disease biomarkers and therapies through integrated omics analyses.
How similar studies have gone: Other COBRE cores have proven the value of integrated omics analyses in accelerating translational research.
Where this research is happening
-
Arkansas Children's Hospital Res Inst
Little Rock, United States Active
Researchers
- Principal investigator: Edmondson, Ricky Dale — Arkansas Children's Hospital Res Inst
- Study coordinator: Edmondson, Ricky Dale
Related research
Other NIH-funded projects on the same topics.
-
Shorter antifungal treatment for kids with candidemia
A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.
-
Short Course vs Standard Course Antifungal Therapy for Pediatric Candidemia
This study tests whether a shorter 7-day total antifungal treatment after an initial 7 days of echinocandin therapy is as effective as the usual 14-day course for children with candidemia.
-
Shorter antifungal treatment for kids with candidemia
A multi-center study tests whether kids with candidemia can finish treatment earlier after an initial week of antifungal therapy than the standard two weeks total.
-
Shorter antifungal treatment for kids with candidemia
This study tests whether children with candidemia can finish treatment after 7 days of an echinocandin if they are improving, instead of completing a full 14 days.
-
Shorter antifungal course for kids with candidemia
A multi-center study tests whether 7 extra days of antifungal therapy after an initial week of treatment can be shortened safely for children with candidemia.
-
Shortened antifungal treatment for kids with candidemia
A pediatric multicenter trial will test whether stopping antifungal therapy after 7 more days, following an initial 7 days of treatment, isas safe as continuing for 14 days.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.